1 terminated, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Laryngomalacia: new trials by email Literature Review of Laryngomalacia trials Research Report on Laryngomalacia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia Famotidine, Speech Language Therapy - Laryngomalacia, Gastro Esophageal Reflux | Phase 1 / Phase 2 | Terminated | Reema Padia | 65 | 2020-11-18 | 2025-07-20 |
| Laryngomalacia Study Omeprazole, Placebo - Laryngomalacia | Phase 1 | Withdrawn | Children's & Women's Health Centre of British Columbia | 2013-02-01 | 2015-07-30 |
Gastroesophageal Reflux (2) · Communication Disorders (1)
Cartilage Diseases (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Connective Tissue Diseases (2) · Deglutition Disorders (2) · Digestive System Diseases (2) · Esophageal Diseases (2) · Esophageal Motility Disorders (2) · Gastrointestinal Diseases (2) · Laryngeal Diseases (2) · Musculoskeletal Abnormalities (2) · Musculoskeletal Diseases (2) · Otorhinolaryngologic Diseases (2) · Respiratory Tract Diseases (2) · Skin and Connective Tissue Diseases (2)
Famotidine (1) · Omeprazole (1) · Speech Therapy (1)
Children's & Women's Health Centre of British Columbia (1) · Reema Padia (1)
Canada (1) · United States (1)
Neil K Chadha, MBChB(Hons)MPHeBSc(Hons)FRCS (1) · Reema Padia, MD (1)